In the preceding three months, 8 analysts have released ratings for Hims & Hers Health (NYSE:HIMS), presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Insights from analysts’ 12-month price targets are revealed, presenting an average target of $21.75, a high estimate of $25.00, and a low estimate of $18.00. This upward trend is apparent, with the current average reflecting a 31.26% increase from the previous average …